{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T19:08:04Z","timestamp":1759777684694},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2015,3,3]],"date-time":"2015-03-03T00:00:00Z","timestamp":1425340800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1007\/s00277-015-2339-6","type":"journal-article","created":{"date-parts":[[2015,3,2]],"date-time":"2015-03-02T02:26:08Z","timestamp":1425263168000},"page":"1185-1193","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Suggestion of response evaluation criteria in patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma (OAML)"],"prefix":"10.1007","volume":"94","author":[{"given":"Su Kyung","family":"Jung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji Sun","family":"Paik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Eun","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gyeongsin","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byung-Ock","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Kyoung","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong Gyu","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suk Woo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seok-Goo","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,3]]},"reference":[{"key":"2339_CR1","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1002\/1097-0142(19940501)73:9<2395::AID-CNCR2820730924>3.0.CO;2-V","volume":"73","author":"O Bairey","year":"1994","unstructured":"Bairey O, Kremer I, Rakowsky E, Hadar H, Shaklai M (1994) Orbital and adnexal involvement in systemic non-Hodgkin\u2019s lymphoma. Cancer 73:2395\u20132399","journal-title":"Cancer"},{"key":"2339_CR2","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s00417-003-0831-5","volume":"242","author":"SE Coupland","year":"2004","unstructured":"Coupland SE, Hellmich M, Auw-Haedrich C, Lee WR, Stein H (2004) Prognostic value of cell-cycle markers in ocular adnexal lymphoma: an assessment of 230 cases. Graefes Arch Clin Exp Ophthalmol 242:130\u2013145. doi: 10.1007\/s00417-003-0831-5","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2339_CR3","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1182\/blood-2006-02-005017","volume":"108","author":"D Decaudin","year":"2006","unstructured":"Decaudin D, de Cremoux P, Vincent-Salomon A, Dendale R, Rouic LL (2006) Ocular adnexal lymphoma: a review of clinicopathologic features and treatment options. Blood 108:1451\u20131460. doi: 10.1182\/blood-2006-02-005017","journal-title":"Blood"},{"key":"2339_CR4","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1001\/archopht.120.9.1180","volume":"120","author":"B Esmaeli","year":"2002","unstructured":"Esmaeli B, Murray JL, Ahmadi MA, Naderi A, Singh S, Romaguera J, White CA, McLaughlin P (2002) Immunotherapy for low-grade non-Hodgkin secondary lymphoma of the orbit. Arch Ophthalmol 120:1225\u20131227","journal-title":"Arch Ophthalmol"},{"key":"2339_CR5","first-page":"214","volume-title":"WHO Classification of tumours of haematopoietic and lymphoid tissues","author":"PG Isaacson","year":"2008","unstructured":"Isaacson PG, Chott A, Nakumura S, M\u00fcller-Hermelink HK, Harris NL, Swerdlow SH (2008) Extranodal marginal cell lymphoma of mucosa-associated tissue (MALT lymphoma). In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds) WHO Classification of tumours of haematopoietic and lymphoid tissues, 4th edn. IARC, Lyon, pp 214\u2013217","edition":"4"},{"key":"2339_CR6","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.ajo.2008.03.013","volume":"145","author":"FA Jakobiec","year":"2008","unstructured":"Jakobiec FA (2008) Ocular adnexal lymphoid tumors: progress in need of clarification. Am J Ophthalmol 145:941\u2013950. doi: 10.1016\/j.ajo.2008.03.013","journal-title":"Am J Ophthalmol"},{"key":"2339_CR7","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1136\/bjo.84.8.907","volume":"84","author":"C Jenkins","year":"2000","unstructured":"Jenkins C, Rose GE, Bunce C, Wright JE, Cree IA, Plowman N, Lightman S, Moseley I, Norton A (2000) Histological features of ocular adnexal lymphoma (REAL classification) and their association with patient morbidity and survival. Br J Ophthalmol 84:907\u2013913. doi: 10.1136\/bjo.84.8.907","journal-title":"Br J Ophthalmol"},{"key":"2339_CR8","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.ophtha.2003.01.002","volume":"111","author":"JA Shields","year":"2004","unstructured":"Shields JA, Shields CL, Scartozzi R (2004) Survey of 1264 patients with orbital tumors and simulating lesions: the 2002 Montgomery Lecture, part 1. Ophthalmology 111:997\u20131008. doi: 10.1016\/j.ophtha.2003.01.002","journal-title":"Ophthalmology"},{"key":"2339_CR9","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3928\/15428877-20070701-08","volume":"38","author":"I Gayed","year":"2007","unstructured":"Gayed I, Eskandari MF, McLaughlin P, Pro B, Diba R, Esmaeli B (2007) Value of positron emission tomography in staging ocular adnexal lymphomas and evaluating their response to therapy. Ophthalmic Surg Lasers Imaging 38:319\u2013325","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"2339_CR10","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","volume":"25","author":"BD Cheson","year":"2007","unstructured":"Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, Coiffier B, Fisher RI, Hagenbeek A, Zucca E, Rosen ST, Stroobants S, Lister TA, Hoppe RT, Dreyling M, Tobinai K, Vose JM, Connors JM, Federico M, Diehl V (2007) Revised response criteria for malignant lymphoma. J Clin Oncol 25:579\u2013586. doi: 10.1200\/JCO.2006.09.2403","journal-title":"J Clin Oncol"},{"key":"2339_CR11","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/00002341-199905000-00006","volume":"15","author":"TE Johnson","year":"1999","unstructured":"Johnson TE, Tse DT, Byrne GE Jr, Restrepo A, Whitcomb CC, Voigt W, Benedetto P, Curtin V (1999) Ocular-adnexal lymphoid tumors: a clinicopathologic and molecular genetic study of 77 patients. Ophthal Plast Reconstr Surg 15:171\u2013179","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"2339_CR12","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0360-3016(02)04159-7","volume":"55","author":"S Martinet","year":"2003","unstructured":"Martinet S, Ozsahin M, Belkac\u00e9mi Y, Landmann C, Poortmans P, Oehlere C, Scandolaro L, Krengli M, Maingon P, Miralbell R, Studer G, Chauvet B, Marnitz S, Zouhair A, Mirimanoff RO (2003) Outcome and prognostic factors in orbital lymphoma: a Rare Cancer Network study on 90 consecutive patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 55:892\u2013898. doi: 10.1016\/S0360-3016(02)04159-7","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2339_CR13","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0360-3016(03)00506-6","volume":"57","author":"M Hasegawa","year":"2003","unstructured":"Hasegawa M, Kojima M, Shioya M, Tamaki Y, Saitoh J, Sakurai H, Kitamoto Y, Suzuki Y, Niibe H, Nakano T (2003) Treatment results of radiotherapy for malignant lymphoma of the orbit and histopathologic review according to the WHO classification. Int J Radiat Oncol Biol Phys 57:172\u2013176. doi: 10.1016\/S0360-3016(03)00506-6","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2339_CR14","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s00277-012-1469-3","volume":"91","author":"JS Paik","year":"2012","unstructured":"Paik JS, Cho WK, Lee SE, Choi BO, Jung SE, Park GS, Kim SH, Yang SW, Cho SG (2012) Ophthalmologic outcomes after chemotherapy and\/or radiotherapy in non-conjunctival ocular adnexal MALT lymphoma. Ann Hematol 91:1393\u20131401. doi: 10.1007\/s00277-012-1469-3","journal-title":"Ann Hematol"},{"key":"2339_CR15","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1200\/JCO.2003.06.085","volume":"21","author":"RW Tsang","year":"2003","unstructured":"Tsang RW, Gospodarowicz MK, Pintilie M, Wells W, Hodgson DC, Sun A, Crump M, Patterson BJ (2003) Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome. J Clin Oncol 21:4157\u20134164. doi: 10.1200\/JCO.2003.06.085","journal-title":"J Clin Oncol"},{"key":"2339_CR16","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1002\/cncr.11317","volume":"97","author":"C Wenzel","year":"2003","unstructured":"Wenzel C, Fiebiger W, Dieckmann K, Formanek M, Chott A, Raderer M (2003) Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue of the head and neck area: high rate of disease recurrence following local therapy. Cancer 97:2236\u20132241. doi: 10.1002\/cncr.11317","journal-title":"Cancer"},{"key":"2339_CR17","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/jnci\/91.6.523","volume":"91","author":"K James","year":"1999","unstructured":"James K, Eisenhauer E, Christian M, Terenziani M, Vena D, Muldal A, Therasse P (1999) Measuring response in solid tumors: unidimensional versus bidimensional measurement. J Natl Cancer Inst 91:523\u2013528","journal-title":"J Natl Cancer Inst"},{"key":"2339_CR18","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1259\/bjr.74.887.740983","volume":"74","author":"AR Padhani","year":"2001","unstructured":"Padhani AR, Ollivier L (2001) The RECIST (Response Evaluation Criteria in Solid Tumors) criteria: implications for diagnostic radiologists. Br J Radiol 74:983\u2013986","journal-title":"Br J Radiol"},{"key":"2339_CR19","doi-asserted-by":"crossref","first-page":"e104004","DOI":"10.1371\/journal.pone.0104004","volume":"9","author":"B Kiesewetter","year":"2014","unstructured":"Kiesewetter B, Lukas J, Kuchar A, Mayerhoefer ME, Streubel B, Lagler H, Mullauer L, Wohrer S, Fischbach J, Raderer M (2014) Clinical features, treatment and outcome of mucosa-associated lymphoid tissue (MALT) lymphoma of the ocular adnexa: single center experience of 60 patients. PLoS One 9:e104004","journal-title":"PLoS One"},{"key":"2339_CR20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/annonc\/mdj025","volume":"17","author":"K Tanimoto","year":"2006","unstructured":"Tanimoto K, Kaneko A, Suzuki S, Sekiguchi N, Maruyama D, Kim SW, Watanabe T, Kobayashi Y, Kagami Y, Maeshima A, Matsuno Y, Tobinai K (2006) Long-term follow-up results of no initial therapy for ocular adnexal MALT lymphoma. Ann Oncol 17:135\u2013140","journal-title":"Ann Oncol"},{"key":"2339_CR21","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1001\/archopht.125.12.1663","volume":"125","author":"E Hatef","year":"2007","unstructured":"Hatef E, Roberts D, McLaughlin P, Pro B, Esmaeli B (2007) Prevalence and nature of systemic involvement and stage at initial examination in patients with orbital and ocular adnexal lymphoma. Arch Ophthalmol 125:1663\u20131667. doi: 10.1001\/archopht.125.12.1663","journal-title":"Arch Ophthalmol"},{"key":"2339_CR22","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/ajh.21963","volume":"86","author":"SE Lee","year":"2011","unstructured":"Lee SE, Paik JS, Cho WK, Choi BO, Lee SN, Jung SE, Park KS, Kang CS, Kim SH, Yang SW, Cho SG (2011) Feasibility of the TNM-based staging system of ocular adnexal extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). Am J Hematol 86:262\u2013266. doi: 10.1002\/ajh.21963","journal-title":"Am J Hematol"},{"key":"2339_CR23","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4103\/0301-4738.81993","volume":"59","author":"SH Lim","year":"2011","unstructured":"Lim SH, Kang M, Son J (2011) Extranodal marginal zone B cell lymphoma of mucosa-associated lymphoid tissue type of the ocular adnexa: retrospective single institution review of 95 patients. Indian J Ophthalmol 59:273\u2013277. doi: 10.4103\/0301-4738.81993","journal-title":"Indian J Ophthalmol"},{"key":"2339_CR24","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1158\/1078-0432.CCR-04-2282","volume":"11","author":"M Raderer","year":"2005","unstructured":"Raderer M, Streubel B, Woehrer S, Puespoek A, Jaeger U, Formanek M, Chott A (2005) High relapse rate in patients with MALT lymphoma warrants lifelong follow-up. Clin Cancer Res 11:3349\u20133352. doi: 10.1158\/1078-0432.CCR-04-2282","journal-title":"Clin Cancer Res"},{"key":"2339_CR25","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/sj.eye.6700379","volume":"17","author":"C Jenkins","year":"2003","unstructured":"Jenkins C, Rose GE, Bunce C, Cree I, Norton A, Plowman PN, Moseley I, Wright JE (2003) Clinical features associated with survival of patients with lymphoma of the ocular adnexa. Eye (Lond) 17:809\u2013820. doi: 10.1038\/sj.eye.6700379","journal-title":"Eye (Lond)"},{"key":"2339_CR26","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/cncr.22843","volume":"110","author":"A Husain","year":"2007","unstructured":"Husain A, Roberts D, Pro B, McLaughlin P, Esmaeli B (2007) Meta-analyses of the association between Chlamydia psittaci and ocular adnexal lymphoma and the response of ocular adnexal lymphoma to antibiotics. Cancer 110:809\u2013815","journal-title":"Cancer"},{"key":"2339_CR27","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1200\/JCO.2011.41.4466","volume":"30","author":"AJ Ferreri","year":"2012","unstructured":"Ferreri AJ, Govi S, Pasini E, Mappa S, Bertoni F, Zaja F, Montalban C, Stelitano C, Cabrera ME, Giordano Resti A, Politi LS, Doglioni C, Cavalli F, Zucca E, Ponzoni M, Dolcetti R (2012) Chlamydophila psittaci eradication with doxycycline as first-line targeted therapy for ocular adnexae lymphoma: final results of an international phase II trial. J Clin Oncol 30:2988\u20132994","journal-title":"J Clin Oncol"},{"key":"2339_CR28","doi-asserted-by":"crossref","first-page":"258","DOI":"10.6004\/jnccn.2006.0025","volume":"4","author":"AD Zelenetz","year":"2006","unstructured":"Zelenetz AD, Advani RH, Buadi F, Cabanillas F, Caligiuri MA, Czuczman MS, Damon LE, Fayad L, Flinn IW, Forero A, Glenn MJ, Gockerman JP, Gordon LI, Harris NL, Hoppe RT, Kaminski MS, Lacasce AS, Nademanee A, Porcu P, Press O, Prosnitz L, Smith MR, Sotomayor EM, Vose JM, Yahalom J (2006) Non-Hodgkin\u2019s lymphoma. Clinical practice guidelines in oncology. J Natl Compr Cancer Netw 4:258\u2013310","journal-title":"J Natl Compr Cancer Netw"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-015-2339-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-015-2339-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-015-2339-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,30]],"date-time":"2020-08-30T11:35:15Z","timestamp":1598787315000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-015-2339-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,3]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["2339"],"URL":"https:\/\/doi.org\/10.1007\/s00277-015-2339-6","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,3]]}}}